BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-6 out of 6 found
  Current Search:  thalomid: 6     

HTML
100%
Celgene: Solid Balance Sheet and Promising Pipeline
I have been looking for a solid pharmaceutical company to add to my stock portfolio.

I had owned Pfizer (PFE) previously but Pfizer appears to be a drug company with a dearth of drugs in its pipeline.

The days of growth appear over and I...

Seeking Alpha:  Jun 9 2009 12:54PM
Matching: thalomid
Find similar documents
HTML
100%
Research and Markets: A Global Strategic Business Report for Multiple Myeloma Therapeutics in Millions of US$
- Research and Markets (http://www.researchandmarkets.com/research/c20e72/multiple_myeloma_t) has announced the addition of the 'Multiple Myeloma Therapeutics - Global Strategic Business Report' report to their offering.

This report...

DiGiTAL50:  Jun 2 2009 8:42PM
Matching: thalomid
Find similar documents
HTML
100%
Research and Markets: A Global Strategic Business Report for Multiple Myeloma Therapeutics in
BusinessWire - Research and Markets (http://www.researchandmarkets.com/research/c20e72/multiple_myeloma_t) has announced the addition of the 'Multiple Myeloma Therapeutics - Global Strategic Business Report' report to their offering.

This...

Forbes.com:  Jun 2 2009 4:21PM
Matching: thalomid
Find similar documents
HTML
100%
Research and Markets: A Global Strategic Business Report for Multiple Myeloma Therapeutics in Millions of US$
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/c20e72/multiple_myeloma_t) has announced the addition of the '' report to their offering.

This report analyzes the U.S.

market for Multiple Myeloma...

Business Wire:  Jun 2 2009 3:50PM
Matching: thalomid
Find similar documents
HTML
100%
Reportlinker Adds World Multiple Myeloma Therapeutics Market Report
NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report is available in its catalogue.

http://www.reportlinker.com/p0119496/World-Multiple-Myeloma-Therapeutics-Market.html This report analyzes the US market...

Business Wire via Yahoo!:  May 18 2009 9:10AM
Matching: thalomid
Find similar documents
HTML
100%
EntreMed Reports First Quarter 2009 Financial Results
ROCKVILLE, Md., May 6 /PRNewswire-FirstCall/ -- EntreMed, Inc.

(Nasdaq: ENMD - News), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today reported financial results...

PR Newswire via Yahoo!:  May 6 2009 11:29AM
Matching: thalomid
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.